-
1
-
-
79960850180
-
Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta)
-
Dow GS, Gettayacamin M, Hansukjariya P, Imerbsin R, Komcharoen S, Sattabongkot J, Kyle D, Milhous W, Cozens S, Kenworthy D, Miller A, Veazey J, Ohrt C. 2011. Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta). Malar J 10:212. http://dx.doi.org/10.1186/1475-2875-10-212.
-
(2011)
Malar J
, vol.10
, pp. 212
-
-
Dow, G.S.1
Gettayacamin, M.2
Hansukjariya, P.3
Imerbsin, R.4
Komcharoen, S.5
Sattabongkot, J.6
Kyle, D.7
Milhous, W.8
Cozens, S.9
Kenworthy, D.10
Miller, A.11
Veazey, J.12
Ohrt, C.13
-
2
-
-
0001381320
-
Primaquine, SN 13272, a new curative agent in vivax malaria; A preliminary report
-
Edgcomb JH, Arnold J, Yount EH, Jr, Alving AS, Eichelberger L, Jeffery GM, Eyles D, Young MD. 1950. Primaquine, SN 13272, a new curative agent in vivax malaria; a preliminary report. J Natl Malar Soc 9:285-292.
-
(1950)
J Natl Malar Soc
, vol.9
, pp. 285-292
-
-
Edgcomb, J.H.1
Arnold, J.2
Yount, E.H.3
Alving, A.S.4
Eichelberger, L.5
Jeffery, G.M.6
Eyles, D.7
Young, M.D.8
-
3
-
-
84896489887
-
Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): A multicentre, double-blind, randomised, phase 2b dose-selection study
-
Llanos-Cuentas A, Lacerda MV, Rueangweerayut R, Krudsood S, Gupta SK, Kochar SK, Arthur P, Chuenchom N, Mohrle JJ, Duparc S, Ugwuegbulam C, Kleim JP, Carter N, Green JA, Kellam L. 2014. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study. Lancet 383:1049-1058. http://dx.doi.org/10.1016/S0140-6736(13)62568-4.
-
(2014)
Lancet
, vol.383
, pp. 1049-1058
-
-
Llanos-Cuentas, A.1
Lacerda, M.V.2
Rueangweerayut, R.3
Krudsood, S.4
Gupta, S.K.5
Kochar, S.K.6
Arthur, P.7
Chuenchom, N.8
Mohrle, J.J.9
Duparc, S.10
Ugwuegbulam, C.11
Kleim, J.P.12
Carter, N.13
Green, J.A.14
Kellam, L.15
-
4
-
-
0033383602
-
Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand
-
Walsh DS, Looareesuwan S, Wilairatana P, Heppner DG, Jr, Tang DB, Brewer TG, Chokejindachai W, Viriyavejakul P, Kyle DE, Milhous WK, Schuster BG, Horton J, Braitman DJ, Brueckner RP. 1999. Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand. J Infect Dis 180:1282-1287. http://dx.doi.org/10.1086/315034.
-
(1999)
J Infect Dis
, vol.180
, pp. 1282-1287
-
-
Walsh, D.S.1
Looareesuwan, S.2
Wilairatana, P.3
Heppner, D.G.4
Tang, D.B.5
Brewer, T.G.6
Chokejindachai, W.7
Viriyavejakul, P.8
Kyle, D.E.9
Milhous, W.K.10
Schuster, B.G.11
Horton, J.12
Braitman, D.J.13
Brueckner, R.P.14
-
5
-
-
33750512152
-
8-Aminoquinolines: Future role as antiprotozoal drugs
-
Tekwani BL, Walker LA. 2006. 8-Aminoquinolines: future role as antiprotozoal drugs. Curr Opin Infect Dis 19:623-631. http://dx.doi.org/10.1097/QCO.0b013e328010b848.
-
(2006)
Curr Opin Infect Dis
, vol.19
, pp. 623-631
-
-
Tekwani, B.L.1
Walker, L.A.2
-
6
-
-
60549099364
-
Primaquine revisited six decades after its discovery
-
Vale N, Moreira R, Gomes P. 2009. Primaquine revisited six decades after its discovery. Eur J Med Chem 44:937-953. http://dx.doi.org/10.1016/j.ejmech.2008.08.011.
-
(2009)
Eur J Med Chem
, vol.44
, pp. 937-953
-
-
Vale, N.1
Moreira, R.2
Gomes, P.3
-
7
-
-
84884924313
-
Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria
-
Bennett JW, Pybus BS, Yadava A, Tosh D, Sousa JC, McCarthy WF, Deye G, Melendez V, Ockenhouse CF. 2013. Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria. N Engl J Med 369: 1381-1382. http://dx.doi.org/10.1056/NEJMc1301936.
-
(2013)
N Engl J Med
, vol.369
, pp. 1381-1382
-
-
Bennett, J.W.1
Pybus, B.S.2
Yadava, A.3
Tosh, D.4
Sousa, J.C.5
McCarthy, W.F.6
Deye, G.7
Melendez, V.8
Ockenhouse, C.F.9
-
8
-
-
0021998680
-
Pharmacokinetics of primaquine in man. I. Studies of the absolute bioavailability and effects of dose size
-
Mihaly GW, Ward SA, Edwards G, Nicholl DD, Orme ML, Breckenridge AM. 1985. Pharmacokinetics of primaquine in man. I. Studies of the absolute bioavailability and effects of dose size. Br J Clin Pharmacol 19: 745-750.
-
(1985)
Br J Clin Pharmacol
, vol.19
, pp. 745-750
-
-
Mihaly, G.W.1
Ward, S.A.2
Edwards, G.3
Nicholl, D.D.4
Orme, M.L.5
Breckenridge, A.M.6
-
9
-
-
83255188683
-
Improving the therapeutic index of 8-aminoquinolines by the use of drug combinations: Review of the literature and proposal for future investigations
-
Myint HY, Berman J, Walker L, Pybus B, Melendez V, Baird JK, Ohrt C. 2011. Improving the therapeutic index of 8-aminoquinolines by the use of drug combinations: review of the literature and proposal for future investigations. Am J Trop Med Hyg 85:1010-1014. http://dx.doi.org/10.4269/ajtmh.2011.11-0498.
-
(2011)
Am J Trop Med Hyg
, vol.85
, pp. 1010-1014
-
-
Myint, H.Y.1
Berman, J.2
Walker, L.3
Pybus, B.4
Melendez, V.5
Baird, J.K.6
Ohrt, C.7
-
10
-
-
84879082233
-
The metabolism of primaquine to its active metabolite is dependent on CYP 2D6
-
Pybus BS, Marcsisin SR, Jin X, Deye G, Sousa JC, Li Q, Caridha D, Zeng Q, Reichard GA, Ockenhouse C, Bennett J, Walker LA, Ohrt C, Melendez V. 2013. The metabolism of primaquine to its active metabolite is dependent on CYP 2D6. Malar J 12:212. http://dx.doi.org/10.1186/1475-2875-12-212.
-
(2013)
Malar J
, vol.12
, pp. 212
-
-
Pybus, B.S.1
Marcsisin, S.R.2
Jin, X.3
Deye, G.4
Sousa, J.C.5
Li, Q.6
Caridha, D.7
Zeng, Q.8
Reichard, G.A.9
Ockenhouse, C.10
Bennett, J.11
Walker, L.A.12
Ohrt, C.13
Melendez, V.14
-
11
-
-
0021968652
-
Pharmacokinetics of primaquine in man. II. Comparison of acute vs chronic dosage in Thai subjects
-
Ward SA, Mihaly GW, Edwards G, Looareesuwan S, Phillips RE, Chanthavanich P, Warrell DA, Orme ML, Breckenridge AM. 1985. Pharmacokinetics of primaquine in man. II. Comparison of acute vs chronic dosage in Thai subjects. Br J Clin Pharmacol 19:751-755.
-
(1985)
Br J Clin Pharmacol
, vol.19
, pp. 751-755
-
-
Ward, S.A.1
Mihaly, G.W.2
Edwards, G.3
Looareesuwan, S.4
Phillips, R.E.5
Chanthavanich, P.6
Warrell, D.A.7
Orme, M.L.8
Breckenridge, A.M.9
-
12
-
-
0026039418
-
Simultaneous modeling of the pharmacokinetics and methemoglobin pharmacodynamics of an 8-aminoquinoline candidate antimalarial (WR 238605)
-
Brueckner RP, Fleckenstein L. 1991. Simultaneous modeling of the pharmacokinetics and methemoglobin pharmacodynamics of an 8-aminoquinoline candidate antimalarial (WR 238605). Pharm Res 8:1505-1510. http://dx.doi.org/10.1023/A:1015842316177.
-
(1991)
Pharm Res
, vol.8
, pp. 1505-1510
-
-
Brueckner, R.P.1
Fleckenstein, L.2
-
13
-
-
0031836936
-
First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial
-
Brueckner RP, Lasseter KC, Lin ET, Schuster BG. 1998. First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial. Am J Trop Med Hyg 58:645-649.
-
(1998)
Am J Trop Med Hyg
, vol.58
, pp. 645-649
-
-
Brueckner, R.P.1
Lasseter, K.C.2
Lin, E.T.3
Schuster, B.G.4
-
14
-
-
0035678895
-
Population pharmacokinetics of the new antimalarial agent tafenoquine in Thai soldiers
-
Edstein MD, Kocisko DA, Brewer TG, Walsh DS, Eamsila C, Charles BG. 2001. Population pharmacokinetics of the new antimalarial agent tafenoquine in Thai soldiers. Br J Clin Pharmacol 52:663-670. http://dx.doi.org/10.1046/j.1365-2125.2001.01482.x.
-
(2001)
Br J Clin Pharmacol
, vol.52
, pp. 663-670
-
-
Edstein, M.D.1
Kocisko, D.A.2
Brewer, T.G.3
Walsh, D.S.4
Eamsila, C.5
Charles, B.G.6
-
15
-
-
0034031718
-
Measurement of tafenoquine (WR 238605) in human plasma and venous and capillary blood by high-pressure liquid chromatography
-
Kocisko DA, Walsh DS, Eamsila C, Edstein MD. 2000. Measurement of tafenoquine (WR 238605) in human plasma and venous and capillary blood by high-pressure liquid chromatography. Ther Drug Monit 22: 184-189. http://dx.doi.org/10.1097/00007691-200004000-00008.
-
(2000)
Ther Drug Monit
, vol.22
, pp. 184-189
-
-
Kocisko, D.A.1
Walsh, D.S.2
Eamsila, C.3
Edstein, M.D.4
-
16
-
-
84899479595
-
Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections
-
Li Q, O'Neil M, Xie L, Caridha D, Zeng Q, Zhang J, Pybus B, Hickman M, Melendez V. 2014. Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections. Malar J 13:141. http://dx.doi.org/10.1186/1475-2875-13-141.
-
(2014)
Malar J
, vol.13
, pp. 141
-
-
Li, Q.1
O'Neil, M.2
Xie, L.3
Caridha, D.4
Zeng, Q.5
Zhang, J.6
Pybus, B.7
Hickman, M.8
Melendez, V.9
-
17
-
-
0037373440
-
A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum
-
Hale BR, Owusu-Agyei S, Fryauff DJ, Koram KA, Adjuik M, Oduro AR, Prescott WR, Baird JK, Nkrumah F, Ritchie TL, Franke ED, Binka FN, Horton J, Hoffman SL. 2003. A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum. Clin Infect Dis 36:541-549. http://dx.doi.org/10.1086/367542.
-
(2003)
Clin Infect Dis
, vol.36
, pp. 541-549
-
-
Hale, B.R.1
Owusu-Agyei, S.2
Fryauff, D.J.3
Koram, K.A.4
Adjuik, M.5
Oduro, A.R.6
Prescott, W.R.7
Baird, J.K.8
Nkrumah, F.9
Ritchie, T.L.10
Franke, E.D.11
Binka, F.N.12
Horton, J.13
Hoffman, S.L.14
-
18
-
-
0035893187
-
A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria
-
Shanks GD, Oloo AJ, Aleman GM, Ohrt C, Klotz FW, Braitman D, Horton J, Brueckner R. 2001. A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria. Clin Infect Dis 33:1968-1974. http://dx.doi.org/10.1086/324081.
-
(2001)
Clin Infect Dis
, vol.33
, pp. 1968-1974
-
-
Shanks, G.D.1
Oloo, A.J.2
Aleman, G.M.3
Ohrt, C.4
Klotz, F.W.5
Braitman, D.6
Horton, J.7
Brueckner, R.8
-
19
-
-
4944234920
-
Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria
-
Walsh DS, Eamsila C, Sasiprapha T, Sangkharomya S, Khaewsathien P, Supakalin P, Tang DB, Jarasrumgsichol P, Cherdchu C, Edstein MD, Rieckmann KH, Brewer TG. 2004. Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria. J Infect Dis 190:1456-1463. http://dx.doi.org/10.1086/424468.
-
(2004)
J Infect Dis
, vol.190
, pp. 1456-1463
-
-
Walsh, D.S.1
Eamsila, C.2
Sasiprapha, T.3
Sangkharomya, S.4
Khaewsathien, P.5
Supakalin, P.6
Tang, D.B.7
Jarasrumgsichol, P.8
Cherdchu, C.9
Edstein, M.D.10
Rieckmann, K.H.11
Brewer, T.G.12
-
20
-
-
75749100191
-
Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects
-
Nasveld PE, Edstein MD, Reid M, Brennan L, Harris IE, Kitchener SJ, Leggat PA, Pickford P, Kerr C, Ohrt C, Prescott W, Tafenoquine Study Team. 2010. Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects. Antimicrob Agents Chemother 54:792-798. http://dx.doi.org/10.1128/AAC.00354-09.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 792-798
-
-
Nasveld, P.E.1
Edstein, M.D.2
Reid, M.3
Brennan, L.4
Harris, I.E.5
Kitchener, S.J.6
Leggat, P.A.7
Pickford, P.8
Kerr, C.9
Ohrt, C.10
Prescott, W.11
-
21
-
-
84893180299
-
A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area
-
Dow GS, McCarthy WF, Reid M, Smith B, Tang D, Shanks GD. 2014. A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area. Malar J 13:49. http://dx.doi.org/10.1186/1475-2875-13-49.
-
(2014)
Malar J
, vol.13
, pp. 49
-
-
Dow, G.S.1
McCarthy, W.F.2
Reid, M.3
Smith, B.4
Tang, D.5
Shanks, G.D.6
-
22
-
-
84892729101
-
Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: Implications for the 8-aminoquinoline class of anti-malarial compounds
-
Marcsisin SR, Sousa JC, Reichard GA, Caridha D, Zeng Q, Roncal N, McNulty R, Careagabarja J, Sciotti RJ, Bennett JW, Zottig VE, Deye G, Li Q, Read L, Hickman M, Dhammika Nanayakkara NP, Walker LA, Smith B, Melendez V, Pybus BS. 2014. Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds. Malar J 13:2. http://dx.doi.org/10.1186/1475-2875-13-2.
-
(2014)
Malar J
, vol.13
, pp. 2
-
-
Marcsisin, S.R.1
Sousa, J.C.2
Reichard, G.A.3
Caridha, D.4
Zeng, Q.5
Roncal, N.6
McNulty, R.7
Careagabarja, J.8
Sciotti, R.J.9
Bennett, J.W.10
Zottig, V.E.11
Deye, G.12
Li, Q.13
Read, L.14
Hickman, M.15
Dhammika Nanayakkara, N.P.16
Walker, L.A.17
Smith, B.18
Melendez, V.19
Pybus, B.S.20
more..
-
23
-
-
84864473749
-
CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine
-
Pybus BS, Sousa JC, Jin X, Ferguson JA, Christian RE, Barnhart R, Vuong C, Sciotti RJ, Reichard GA, Kozar MP, Walker LA, Ohrt C, Melendez V. 2012. CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine. Malar J 11:259. http://dx.doi.org/10.1186/1475-2875-11-259.
-
(2012)
Malar J
, vol.11
, pp. 259
-
-
Pybus, B.S.1
Sousa, J.C.2
Jin, X.3
Ferguson, J.A.4
Christian, R.E.5
Barnhart, R.6
Vuong, C.7
Sciotti, R.J.8
Reichard, G.A.9
Kozar, M.P.10
Walker, L.A.11
Ohrt, C.12
Melendez, V.13
-
24
-
-
84888042382
-
Pharmacokinetic interactions and safety evaluations of coadministered tafenoquine and chloroquine in healthy subjects
-
Miller AK, Harrell E, Ye L, Baptiste-Brown S, Kleim JP, Ohrt C, Duparc S, Mohrle JJ, Webster A, Stinnett S, Hughes A, Griffith S, Beelen AP. 2013. Pharmacokinetic interactions and safety evaluations of coadministered tafenoquine and chloroquine in healthy subjects. Br J Clin Pharmacol 76:858-867. http://dx.doi.org/10.1111/bcp.12160.
-
(2013)
Br J Clin Pharmacol
, vol.76
, pp. 858-867
-
-
Miller, A.K.1
Harrell, E.2
Ye, L.3
Baptiste-Brown, S.4
Kleim, J.P.5
Ohrt, C.6
Duparc, S.7
Mohrle, J.J.8
Webster, A.9
Stinnett, S.10
Hughes, A.11
Griffith, S.12
Beelen, A.P.13
-
25
-
-
84928902226
-
Differential CYP 2D6 metabolism alters primaquine pharmacokinetics
-
Potter BM, Xie LH, Vuong CT, Zhang J, Zhang P, Duan D, Luong T-LT, Bandara Herath HMT, Dhammika Nanayakkara NP, Tekwani BL, Walker LA, Nolan CK, Sciotti RJ, Zottig VE, Smith PL, Paris RM, Read LT, Li Q, Pybus BS, Sousa JC, Reichard GA, Marcsisin SR. 2015. Differential CYP 2D6 metabolism alters primaquine pharmacokinetics. Antimicrob Agents Chemother 59:2380-2387. http://dx.doi.org/10.1128/AAC.00015-15.
-
(2015)
Antimicrob Agents Chemother
, vol.59
, pp. 2380-2387
-
-
Potter, B.M.1
Xie, L.H.2
Vuong, C.T.3
Zhang, J.4
Zhang, P.5
Duan, D.6
Luong, T.-L.T.7
Bandara Herath, H.M.T.8
Dhammika Nanayakkara, N.P.9
Tekwani, B.L.10
Walker, L.A.11
Nolan, C.K.12
Sciotti, R.J.13
Zottig, V.E.14
Smith, P.L.15
Paris, R.M.16
Read, L.T.17
Li, Q.18
Pybus, B.S.19
Sousa, J.C.20
Reichard, G.A.21
Marcsisin, S.R.22
more..
-
26
-
-
84455162074
-
Modeling human cytochrome P450 2D6 metabolism and drug-drug interaction by a novel panel of knockout and humanized mouse lines
-
Scheer N, Kapelyukh Y, McEwan J, Beuger V, Stanley LA, Rode A, Wolf CR. 2012. Modeling human cytochrome P450 2D6 metabolism and drug-drug interaction by a novel panel of knockout and humanized mouse lines. Mol Pharmacol 81:63-72. http://dx.doi.org/10.1124/mol.111.075192.
-
(2012)
Mol Pharmacol
, vol.81
, pp. 63-72
-
-
Scheer, N.1
Kapelyukh, Y.2
McEwan, J.3
Beuger, V.4
Stanley, L.A.5
Rode, A.6
Wolf, C.R.7
-
27
-
-
33745245269
-
Expression, purification, and characterization of mouse CYP2d22
-
Yu AM, Haining RL. 2006. Expression, purification, and characterization of mouse CYP2d22. Drug Metab Dispos 34:1167-1174. http://dx.doi.org/10.1124/dmd.105.008870.
-
(2006)
Drug Metab Dispos
, vol.34
, pp. 1167-1174
-
-
Yu, A.M.1
Haining, R.L.2
-
28
-
-
1642292958
-
Primaquine-induced hemolytic anemia: Susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine
-
Bowman ZS, Oatis JE, Jr, Whelan JL, Jollow DJ, McMillan DC. 2004. Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine. J Pharmacol Exp Ther 309:79-85. http://dx.doi.org/10.1124/jpet.103.062984.
-
(2004)
J Pharmacol Exp Ther
, vol.309
, pp. 79-85
-
-
Bowman, Z.S.1
Oatis, J.E.2
Whelan, J.L.3
Jollow, D.J.4
McMillan, D.C.5
-
29
-
-
0025013036
-
ESR detection of free radical intermediates during autoxidation of 5-hydroxyprimaquine
-
Vasquez-Vivar J, Augusto O. 1990. ESR detection of free radical intermediates during autoxidation of 5-hydroxyprimaquine. Free Radic Res Commun 9:383-389. http://dx.doi.org/10.3109/10715769009145698.
-
(1990)
Free Radic Res Commun
, vol.9
, pp. 383-389
-
-
Vasquez-Vivar, J.1
Augusto, O.2
-
30
-
-
0026630568
-
Hydroxylated metabolites of the antimalarial drug primaquine. Oxidation and redox cycling
-
Vasquez-Vivar J, Augusto O. 1992. Hydroxylated metabolites of the antimalarial drug primaquine. Oxidation and redox cycling. J Biol Chem 267:6848-6854.
-
(1992)
J Biol Chem
, vol.267
, pp. 6848-6854
-
-
Vasquez-Vivar, J.1
Augusto, O.2
-
31
-
-
0028047135
-
Oxidative activity of primaquine metabolites on rat erythrocytes in vitro and in vivo
-
Vasquez-Vivar J, Augusto O. 1994. Oxidative activity of primaquine metabolites on rat erythrocytes in vitro and in vivo. Biochem Pharmacol 47:309-316. http://dx.doi.org/10.1016/0006-2952(94)90022-1.
-
(1994)
Biochem Pharmacol
, vol.47
, pp. 309-316
-
-
Vasquez-Vivar, J.1
Augusto, O.2
-
32
-
-
0028796504
-
Metabolism of a candidate 8-aminoquinoline antimalarial agent, WR 238605, by rat liver microsomes
-
Idowu OR, Peggins JO, Brewer TG, Kelley C. 1995. Metabolism of a candidate 8-aminoquinoline antimalarial agent, WR 238605, by rat liver microsomes. Drug Metab Dispos 23:1-17.
-
(1995)
Drug Metab Dispos
, vol.23
, pp. 1-17
-
-
Idowu, O.R.1
Peggins, J.O.2
Brewer, T.G.3
Kelley, C.4
-
33
-
-
0028863901
-
The effect of fluorine substitution on the haemotoxicity of primaquine
-
O'Neill P, Tingle MD, Mahmud R, Storr RC, Ward SA, Kevin Park B. 1995. The effect of fluorine substitution on the haemotoxicity of primaquine. Bioorg Med Chem Lett 5:2309-2314. http://dx.doi.org/10.1016/0960-894X(95)00400-N.
-
(1995)
Bioorg Med Chem Lett
, vol.5
, pp. 2309-2314
-
-
O'Neill, P.1
Tingle, M.D.2
Mahmud, R.3
Storr, R.C.4
Ward, S.A.5
Kevin Park, B.6
|